Camino Minerals Corporation Announces Closing of First Tranche of Private Placement Vancouver, BC – Camino Minerals Corporation (TSXV:COR, OTC PINK:CAMZF) (“Camino” or the “Company”), a mineral exploration company, is thrilled to announce the successful completion of the first tranche of its non-brokered private placement (the “Financing”). Details of the Financing Under the terms of the…

Greenwich LifeSciences Expands FLAMINGO-01 Clinical Trial into Europe: A New Hope for Breast Cancer Prevention STAFFORD, Texas, January 29, 2025 – Greenwich LifeSciences, Inc. (GLSI), a pioneering clinical-stage biopharmaceutical company, recently announced the expansion of its Phase III clinical trial, FLAMINGO-01, into Europe. This groundbreaking trial is dedicated to evaluating the efficacy and safety of…

ITT Inc. to Participate in Upcoming Investor Conferences Stamford, CT – ITT Inc. (NYSE: ITT), a leading global technology provider, has announced its intention to attend three investor conferences in February 2025. These conferences are being hosted by TD Cowen, Citi, and Gabelli. TD Cowen Conference The first conference will be held on February 4th,…

W&T Offshore’s Tender Offer: A Game Changer for Bondholders Houston, Texas – January 29, 2025. W&T Offshore, Inc. (WTI), a leading independent explorer and producer of oil and natural gas in the Gulf of Mexico, recently announced the preliminary results of its cash tender offer (Tender Offer) and consent solicitation (Consent Solicitation) for its 11.750%…

Canterra Minerals Unveils Exciting Exploration Plans for Buchans Critical Minerals Project Vancouver, British Columbia – Canterra Minerals Corporation (CTM, CTMCF, DXZB) is thrilled to share its meticulously planned exploration initiatives for the Buchans Critical Minerals Project, situated in the Central Newfoundland Mining District (see Figure 1). Figure 1: Location of the Buchans Critical Minerals Project…

Class Action Lawsuit Filed Against Caribou Biosciences: A Detailed Look On January 29, 2025, Bronstein, Gewirtz & Grossman, LLC, a prominent law firm, announced the filing of a class action lawsuit against Caribou Biosciences, Inc. (Caribou or the Company) and certain of its officers. The lawsuit alleges that the Company and its officers violated federal…

Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from ADPKD Program Regulus Therapeutics, a biopharmaceutical company specializing in the discovery and development of microRNA-targeted medicines, has recently announced encouraging news from its ADPKD (Autosomal Dominant Polycystic Kidney Disease) program. An interim analysis of the fourth cohort of the Phase 1b Multiple-Ascending Dose (MAD) clinical trial…

Bronstein, Gewirtz & Grossman, LLC Investigates Potential Claims against Midland States Bancorp, Inc. On January 29, 2025, Bronstein, Gewirtz & Grossman, LLC, a leading national securities fraud law firm, announced that it is investigating potential claims on behalf of purchasers of Midland States Bancorp, Inc. (Midland States Bancorp or the Company) (NASDAQ: MSBI). Background on…